The meeting was held virtually to help limit the spread of COVID-19.
News
Forxiga successful in DAPA-HF heart failure trial
The new data from the trial “further reinforce Forxiga’s clinical effects beyond diabetes.”
AZ recruits ImaginAb in CD8 ImmunoPET deal
CD8 ImmunoPET minibody works by binding CD8 receptor on human T cells and is used for non-invasive PET imaging of CD8 T cells in patients.
COVID-19: UK commits £210m as pharmacist warns Brits not to stockpile Ventolin inhalers
Thermo Fisher has also announced that it has received the CE mark in the European Union for its diagnostic test.
CHMP gives Sanofi positive opinion for Sarclisa
Despite available treatments, multiple myeloma remains an incurable malignancy, and is associated with significant patient burden.
BMJ journal deems opioid dependency implant more favourable than tablets
While the opioid epidemic in the USA is well documented, Europe also has an estimated 1.3 million high-risk opioid users.
Takeda, Evox link up to the tune of $882m
Evox will offer its preclinical programme in Niemann-Pick disease type C for development, and a second new programme directed at another undisclosed rare disease.
EMA accepts Arvelle’s cenobamate MAA
There are about six million people in Europe with epilepsy, and approximately 40% of adults with focal-onset seizures continue to experience seizures.
COVID-19: ‘Army’ of volunteers join NHS as BMS postpones new study starts
The FDA has also granted Gilead’s wishes to withdraw orphan drug designation for remdesivir under current circumstances.
Astellas, CytomX form T-cell engaging cancer antibodies partnership
Astellas has confirmed that it will make an upfront cash payment of $80 million to CytomX.
Novavax plans FDA filing after NanoFlu trumps Sanofi flu vaccine
The vaccine met all primary endpoints in adults aged 65 and older against Sanofi’s Fluzone Quadrivalent.
Botox gets license update in UK
Previously the licence referred to “physicians”, prompting confusion over who is able to inject the treatment.
Bayer enlists Curadev in STING antagonist collaboration
STING is known to play a role in activating the innate immune system in auto-inflammatory diseases.
Hep C cases down around 70% in HIV positive men in London and Brighton
Regular hepatitis C screening and improved access to new treatments has potentially contributed to greatly reducing the transmission of the infection.
COVID-19: AstraZeneca to distribute masks as ASCO goes virtual
PHE has also been awarded $500,000 by the US FDA to bolster the international response.
